JP6453222B2 - ジアザビシクロオクタン誘導体の製造法とその中間体 - Google Patents
ジアザビシクロオクタン誘導体の製造法とその中間体 Download PDFInfo
- Publication number
- JP6453222B2 JP6453222B2 JP2015539238A JP2015539238A JP6453222B2 JP 6453222 B2 JP6453222 B2 JP 6453222B2 JP 2015539238 A JP2015539238 A JP 2015539238A JP 2015539238 A JP2015539238 A JP 2015539238A JP 6453222 B2 JP6453222 B2 JP 6453222B2
- Authority
- JP
- Japan
- Prior art keywords
- benzyloxy
- tert
- amino
- mixture
- piperidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 *NCCONC([C@@](CCCCC1)N1C(NOCc1ccccc1)=O)=O Chemical compound *NCCONC([C@@](CCCCC1)N1C(NOCc1ccccc1)=O)=O 0.000 description 4
- JFOUQKFFNNJVRJ-INIZCTEOSA-N CC(C)(C)OC(N(CC1(CC1)CC1)[C@@H]1C(OCc1ccccc1)=O)=O Chemical compound CC(C)(C)OC(N(CC1(CC1)CC1)[C@@H]1C(OCc1ccccc1)=O)=O JFOUQKFFNNJVRJ-INIZCTEOSA-N 0.000 description 1
- NKVVTENKCMXHNY-NQIIRXRSSA-N CC(C)(C)OC(N(C[C@@H](CC1)NOCc2ccccc2)[C@@H]1C(O[n]1nnc2c1cccc2)=O)=O Chemical compound CC(C)(C)OC(N(C[C@@H](CC1)NOCc2ccccc2)[C@@H]1C(O[n]1nnc2c1cccc2)=O)=O NKVVTENKCMXHNY-NQIIRXRSSA-N 0.000 description 1
- GLPJKOVGICTVBQ-XLIONFOSSA-N CC(C)(C)OC(N(C[C@@H](CC1)NOCc2ccccc2)[C@@H]1C(Oc(c(Cl)cc(Cl)c1)c1Cl)=O)=O Chemical compound CC(C)(C)OC(N(C[C@@H](CC1)NOCc2ccccc2)[C@@H]1C(Oc(c(Cl)cc(Cl)c1)c1Cl)=O)=O GLPJKOVGICTVBQ-XLIONFOSSA-N 0.000 description 1
- IHBOAMANDPAESJ-CTNGQTDRSA-N CC(C)(C)OC(N(C[C@@H](CC1)NOCc2ccccc2)[C@@H]1C(Oc(cc1)ccc1C(N)=O)=O)=O Chemical compound CC(C)(C)OC(N(C[C@@H](CC1)NOCc2ccccc2)[C@@H]1C(Oc(cc1)ccc1C(N)=O)=O)=O IHBOAMANDPAESJ-CTNGQTDRSA-N 0.000 description 1
- ALHJASVQSVZADW-SFHVURJKSA-N CC(C)(C)OC(NCCONC([C@H](CCCCC1)N1C(NOCc1ccccc1)=O)=O)=O Chemical compound CC(C)(C)OC(NCCONC([C@H](CCCCC1)N1C(NOCc1ccccc1)=O)=O)=O ALHJASVQSVZADW-SFHVURJKSA-N 0.000 description 1
- MEQZWILNPLMCMK-SJORKVTESA-N CC(C)(C)OC(NCCONC([C@H](CC[C@H](C1)N2OCc3ccccc3)N1C2=O)=O)=O Chemical compound CC(C)(C)OC(NCCONC([C@H](CC[C@H](C1)N2OCc3ccccc3)N1C2=O)=O)=O MEQZWILNPLMCMK-SJORKVTESA-N 0.000 description 1
- PLZIKDSHMHHBIZ-QWNQHWSFSA-N O=C([C@H](CC(C1)[C@@H]1C1)N1C(NOCc1ccccc1)=O)ON(C(CC1C2[C@H]3C=C[C@@H]1C3)=O)C2=O Chemical compound O=C([C@H](CC(C1)[C@@H]1C1)N1C(NOCc1ccccc1)=O)ON(C(CC1C2[C@H]3C=C[C@@H]1C3)=O)C2=O PLZIKDSHMHHBIZ-QWNQHWSFSA-N 0.000 description 1
- DQSAYRQUNMRPAG-HNNXBMFYSA-N O=C([C@H](CCCCC1)N1C(NOCc1ccccc1)=O)ON(C(CC1)=O)C1=O Chemical compound O=C([C@H](CCCCC1)N1C(NOCc1ccccc1)=O)ON(C(CC1)=O)C1=O DQSAYRQUNMRPAG-HNNXBMFYSA-N 0.000 description 1
- KGYAFGBSKFZLDD-KIYNQFGBSA-N OC([C@H](CCC(C1)NOCc2ccccc2)N1P)=O Chemical compound OC([C@H](CCC(C1)NOCc2ccccc2)N1P)=O KGYAFGBSKFZLDD-KIYNQFGBSA-N 0.000 description 1
- IIRLRKGCUHXKBX-MJGOQNOKSA-N [O-][N+](c(cc1)ccc1OCC([C@H](CC[C@H](C1)N2OCc3ccccc3)N1C2=O)=O)=O Chemical compound [O-][N+](c(cc1)ccc1OCC([C@H](CC[C@H](C1)N2OCc3ccccc3)N1C2=O)=O)=O IIRLRKGCUHXKBX-MJGOQNOKSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013197110 | 2013-09-24 | ||
| JP2013197110 | 2013-09-24 | ||
| PCT/JP2014/075203 WO2015046207A1 (ja) | 2013-09-24 | 2014-09-24 | ジアザビシクロオクタン誘導体の製造法とその中間体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2015046207A1 JPWO2015046207A1 (ja) | 2017-03-09 |
| JP6453222B2 true JP6453222B2 (ja) | 2019-01-16 |
Family
ID=52743343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015539238A Active JP6453222B2 (ja) | 2013-09-24 | 2014-09-24 | ジアザビシクロオクタン誘導体の製造法とその中間体 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US10000491B2 (https=) |
| EP (1) | EP3050883B1 (https=) |
| JP (1) | JP6453222B2 (https=) |
| KR (1) | KR102239725B1 (https=) |
| CN (2) | CN107501264A (https=) |
| AR (5) | AR097744A1 (https=) |
| AU (1) | AU2014324302B2 (https=) |
| BR (1) | BR112016006246B8 (https=) |
| CA (1) | CA2924953C (https=) |
| DK (1) | DK3050883T3 (https=) |
| ES (1) | ES2793201T3 (https=) |
| HK (1) | HK1244487A1 (https=) |
| HU (1) | HUE049027T2 (https=) |
| IL (1) | IL244740B (https=) |
| MX (2) | MX372585B (https=) |
| MY (2) | MY176278A (https=) |
| NZ (1) | NZ718009A (https=) |
| RU (1) | RU2719480C2 (https=) |
| SG (1) | SG11201602256UA (https=) |
| TW (1) | TWI644908B (https=) |
| WO (1) | WO2015046207A1 (https=) |
| ZA (1) | ZA201602053B (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2016088863A1 (ja) * | 2014-12-05 | 2017-09-14 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | ジアザビシクロオクタン誘導体の結晶及び安定な凍結乾燥製剤の製造法 |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2693898C2 (ru) | 2012-05-30 | 2019-07-05 | Мейдзи Сейка Фарма Ко., Лтд. | НОВЫЙ ИНГИБИТОР бета-ЛАКТАМАЗЫ И СПОСОБ ЕГО ПОЛУЧЕНИЯ |
| DK3050883T3 (da) | 2013-09-24 | 2020-05-25 | Meiji Seika Pharma Co Ltd | Fremgangsmåde til fremstilling af diazabicyclooctanderivater og mellemprodukter |
| EP3613740A1 (en) | 2013-10-08 | 2020-02-26 | Meiji Seika Pharma Co., Ltd. | Preparation of a diazabicyclooctane derivative |
| CA2944306C (en) | 2015-10-30 | 2023-11-14 | The Toronto-Dominion Bank | Validating encrypted data from a multi-layer token |
| US11216808B2 (en) | 2015-11-04 | 2022-01-04 | The Toronto-Dominion Bank | Token-based system for excising data from databases |
| JP2020011901A (ja) * | 2016-10-20 | 2020-01-23 | 協和キリン株式会社 | ピロリジン化合物の製造方法 |
| CN106699756B (zh) * | 2016-12-30 | 2019-10-29 | 淄博鑫泉医药技术服务有限公司 | β内酰胺酶抑制剂阿维巴坦的合成方法 |
| US10584123B2 (en) | 2017-09-27 | 2020-03-10 | Fedora Pharmaceuticals Inc. | Pharmaceutical forms of diazabicyclooctane derivatives and manufacturing method thereof |
| WO2019064065A1 (en) | 2017-09-27 | 2019-04-04 | F. Hoffmann-La Roche Ag | PHARMACEUTICAL FORMS OF DIAZABICYCLOOCTANE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF |
| KR20200091395A (ko) | 2017-09-27 | 2020-07-30 | 페도라 파마슈티칼스 인코포레이티드 | 디아자비시클로옥탄 유도체의 결정형 및 그의 제조 방법 |
| CN109678856B (zh) * | 2017-10-18 | 2020-09-25 | 新发药业有限公司 | 一种阿维巴坦中间体的制备方法 |
| CN111373033A (zh) | 2017-11-23 | 2020-07-03 | 豪夫迈·罗氏有限公司 | 脯氨酸羟化酶及其相关用途、方法和产品 |
| WO2020018462A1 (en) | 2018-07-16 | 2020-01-23 | Brown University | A chromogenic beta-lactamase substrate |
| CN119707784A (zh) * | 2018-09-21 | 2025-03-28 | 株式会社Api | 氨基酸衍生物的制备方法 |
| US12195755B2 (en) | 2019-05-20 | 2025-01-14 | Brown University | Placental lipid bilayer for cell-free molecular interaction studies |
| US11751775B2 (en) | 2019-08-30 | 2023-09-12 | DePuy Synthes Products, Inc. | Electrical device for monitoring, prevention, and treatment of implant infections |
| WO2021087008A1 (en) | 2019-10-28 | 2021-05-06 | Brown University | Bacterial beta-lactamase responsive hydrogels |
| CN121021508B (zh) * | 2025-10-29 | 2026-02-24 | 北京耀诚惠仁科技有限公司 | β-内酰胺酶抑制剂中间体共晶或盐及其制备方法和应用 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5038509B1 (https=) | 1970-10-21 | 1975-12-10 | ||
| JPS538509A (en) | 1976-07-13 | 1978-01-26 | Toshiba Corp | Impedance matching system for data transmission circuit |
| JPS6019759B2 (ja) | 1977-11-24 | 1985-05-17 | イ−ライ・リリ−・アンド・カンパニ− | 非経口投予用１１１１５１５２１３９１９９東京都中央区京橋２丁目３番１３号 |
| GB1589317A (en) | 1977-11-24 | 1981-05-13 | Lilly Co Eli | Freeze drying cephalothin sodium |
| JPS60255723A (ja) | 1984-05-31 | 1985-12-17 | Ono Pharmaceut Co Ltd | メシル酸ガベキサートの結晶性凍結乾燥製剤及びその製造方法 |
| JPH07117533B2 (ja) | 1985-08-28 | 1995-12-18 | 株式会社生体科学研究所 | トランスフエリンおよびその用途 |
| US20030220521A1 (en) | 1989-07-27 | 2003-11-27 | G.D. Searle & Co. | Renal-selective prodrugs for control of renal sympathetic nerve activity in the treatment of hypertension |
| TW264475B (https=) | 1991-09-20 | 1995-12-01 | Takeda Pharm Industry Co Ltd | |
| HUT74682A (en) * | 1993-12-29 | 1997-01-28 | Pfizer | Diazabicyclic neurokinin antagonists and pharmaceutical compositions containing them |
| JP2843444B2 (ja) | 1994-05-02 | 1999-01-06 | 塩野義製薬株式会社 | ピロリジルチオカルバペネム誘導体の結晶，該結晶を含む凍結乾燥製剤，およびその製造方法 |
| WO1995029913A1 (en) | 1994-05-02 | 1995-11-09 | Shionogi & Co., Ltd. | Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same |
| FR2812635B1 (fr) | 2000-08-01 | 2002-10-11 | Aventis Pharma Sa | Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens |
| FR2815420B1 (fr) | 2000-10-16 | 2003-05-16 | Cit Alcatel | Compensation de la dispersion chromatique dans un systeme de transmission a fibre optique, et fibre de compensation |
| FR2825705B1 (fr) | 2001-06-08 | 2005-05-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens |
| FR2835186B1 (fr) | 2002-01-28 | 2006-10-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases |
| FR2921060B1 (fr) | 2007-09-14 | 2012-06-15 | Novexel | Nouveau procede de preparation d'une piperidine disubsituee et nouveaux intermediaires |
| ES2533826T3 (es) | 2008-01-18 | 2015-04-15 | Merck Sharp & Dohme Corp. | Inhibidores de beta-lactamasa |
| FR2930553B1 (fr) | 2008-04-29 | 2010-05-21 | Novexel | Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment inhibiteurs de beta-lactamases |
| FR2936798B1 (fr) | 2008-10-03 | 2012-09-28 | Novexel | Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens. |
| US20120053350A1 (en) | 2009-04-30 | 2012-03-01 | Ian Mangion | Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids |
| FR2951171A1 (fr) | 2009-10-09 | 2011-04-15 | Novexel | Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation |
| JP2012122603A (ja) | 2010-11-15 | 2012-06-28 | Nifco Inc | コネクタ装置 |
| SI2657234T1 (sl) * | 2010-12-22 | 2017-06-30 | Meiji Seika Pharma Co., Ltd. | Derivat optično-aktivnega diazabiciklooktana in metoda za njegovo izdelavo |
| US8772490B2 (en) | 2010-12-22 | 2014-07-08 | Meiji Seika Pharma Co., Ltd. | Optically active diazabicyclooctane derivatives and process for preparing the same |
| KR102143660B1 (ko) * | 2011-06-17 | 2020-08-11 | 화이자 안티-인펙티브스 에이비 | 트랜스-7-옥소-6-(술포옥시)-1,6-디아자비시클로[3,2,1]옥탄-2-카르복스아미드 및 그의 염을 포함하는 헤테로시클릭 화합물의 제조 방법 |
| RU2578370C2 (ru) | 2011-08-27 | 2016-03-27 | Вокхардт Лимитед | Производные 1,6- диазабицикло [3,2,1] октан-7-она и их применение при лечении бактериальных инфекционных болезней |
| MX340533B (es) | 2011-08-30 | 2016-07-13 | Wockhardt Ltd | Derivados de 1,6- diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas. |
| EP3052497B1 (en) | 2011-09-13 | 2017-06-28 | Wockhardt Limited | Nitrogen containing compounds and their use |
| US9505761B2 (en) | 2011-12-02 | 2016-11-29 | Fedora Pharmaceuticals Inc. | Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors |
| US8796257B2 (en) | 2011-12-02 | 2014-08-05 | Naeja Pharmaceutical Inc. | Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors |
| RU2693898C2 (ru) | 2012-05-30 | 2019-07-05 | Мейдзи Сейка Фарма Ко., Лтд. | НОВЫЙ ИНГИБИТОР бета-ЛАКТАМАЗЫ И СПОСОБ ЕГО ПОЛУЧЕНИЯ |
| DK3050883T3 (da) | 2013-09-24 | 2020-05-25 | Meiji Seika Pharma Co Ltd | Fremgangsmåde til fremstilling af diazabicyclooctanderivater og mellemprodukter |
| EP3613740A1 (en) | 2013-10-08 | 2020-02-26 | Meiji Seika Pharma Co., Ltd. | Preparation of a diazabicyclooctane derivative |
-
2014
- 2014-09-24 DK DK14847854.8T patent/DK3050883T3/da active
- 2014-09-24 ES ES14847854T patent/ES2793201T3/es active Active
- 2014-09-24 AU AU2014324302A patent/AU2014324302B2/en active Active
- 2014-09-24 JP JP2015539238A patent/JP6453222B2/ja active Active
- 2014-09-24 AR ARP140103525A patent/AR097744A1/es active IP Right Grant
- 2014-09-24 MX MX2019006550A patent/MX372585B/es unknown
- 2014-09-24 KR KR1020167009769A patent/KR102239725B1/ko active Active
- 2014-09-24 MY MYPI2016700980A patent/MY176278A/en unknown
- 2014-09-24 MX MX2016003867A patent/MX367578B/es active IP Right Grant
- 2014-09-24 US US15/023,976 patent/US10000491B2/en active Active
- 2014-09-24 MY MYPI2019004461A patent/MY193210A/en unknown
- 2014-09-24 SG SG11201602256UA patent/SG11201602256UA/en unknown
- 2014-09-24 RU RU2016115767A patent/RU2719480C2/ru active
- 2014-09-24 CN CN201710665418.8A patent/CN107501264A/zh active Pending
- 2014-09-24 CA CA2924953A patent/CA2924953C/en active Active
- 2014-09-24 HU HUE14847854A patent/HUE049027T2/hu unknown
- 2014-09-24 NZ NZ718009A patent/NZ718009A/en unknown
- 2014-09-24 CN CN201480052097.9A patent/CN105555787B/zh active Active
- 2014-09-24 BR BR112016006246A patent/BR112016006246B8/pt active IP Right Grant
- 2014-09-24 TW TW103132937A patent/TWI644908B/zh active
- 2014-09-24 WO PCT/JP2014/075203 patent/WO2015046207A1/ja not_active Ceased
- 2014-09-24 EP EP14847854.8A patent/EP3050883B1/en active Active
-
2016
- 2016-03-23 IL IL244740A patent/IL244740B/en active IP Right Grant
- 2016-03-29 ZA ZA2016/02053A patent/ZA201602053B/en unknown
- 2016-06-24 HK HK18103950.2A patent/HK1244487A1/zh unknown
-
2017
- 2017-06-05 US US15/613,620 patent/US10000492B2/en active Active
-
2023
- 2023-11-28 AR ARP230103205A patent/AR131186A2/es unknown
- 2023-11-28 AR ARP230103208A patent/AR131189A2/es unknown
- 2023-11-28 AR ARP230103209A patent/AR131190A2/es unknown
- 2023-11-28 AR ARP230103207A patent/AR131188A2/es unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2016088863A1 (ja) * | 2014-12-05 | 2017-09-14 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | ジアザビシクロオクタン誘導体の結晶及び安定な凍結乾燥製剤の製造法 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6453222B2 (ja) | ジアザビシクロオクタン誘導体の製造法とその中間体 | |
| JP7182677B2 (ja) | ジアザビシクロオクタン誘導体の結晶とその製造法 | |
| ES2758507T3 (es) | Nuevo inhibidor de B-lactamasa y método para producir el mismo | |
| HK1226406A1 (en) | Production method for diazabicyclooctane derivatives and intermediates | |
| HK1219473B (en) | Production method for diazabicyclooctane derivative and intermediary body thereof | |
| RU2838718C2 (ru) | Кристаллические формы производного диазабициклооктана и способ их получения | |
| RU2800050C2 (ru) | НОВЫЙ ИНГИБИТОР β-ЛАКТАМАЗЫ И СПОСОБ ЕГО ПОЛУЧЕНИЯ | |
| RU2801220C2 (ru) | Кристаллические формы производного диазабициклооктана и способ их получения | |
| HK1226406B (en) | Production method for diazabicyclooctane derivatives and intermediates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170814 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180619 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20180813 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181011 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20181113 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20181212 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6453222 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |